Difficulty: Medium
Average Score: 79%
Practice
The client with a diagnosis of heart failure is receiving furosemide (Lasix). Which laboratory value is most important for the nurse to monitor?
Correct answer
C
Rationale
In the context of a client with heart failure receiving furosemide (Lasix), the most important laboratory value for the nurse to monitor is serum potassium (Option C). Furosemide is a loop diuretic that works by promoting the excretion of water and electrolytes, including potassium, from the body. Hypokalemia (low potassium levels) is a common side effect of furosemide therapy and can lead to serious cardiac complications, especially in patients with heart failure.
Monitoring serum potassium levels is crucial to prevent adverse effects such as cardiac dysrhythmias, muscle weakness, and potential worsening of heart failure symptoms. Therefore, regular assessment of potassium levels allows for prompt intervention, such as potassium supplementation or adjusting the dosage of furosemide, to maintain electrolyte balance and optimize the client's cardiac function.
Regarding the other options:
- Blood glucose (Option A) is not directly related to furosemide therapy in heart failure.
- Serum sodium (Option B) may be affected by furosemide but is not as critical as monitoring potassium levels in this context.
- Blood urea nitrogen (BUN) (Option D) is an indicator of kidney function but is not the most crucial parameter to monitor when assessing the impact of furosemide on a client with heart failure.
Understanding the rationale behind prioritizing serum potassium monitoring in this scenario is essential for nurses caring for clients with heart failure receiving diuretic therapy. It emphasizes the significance of anticipating and managing potential electrolyte imbalances to promote positive patient outcomes and prevent complications related to medication therapy.
Monitoring serum potassium levels is crucial to prevent adverse effects such as cardiac dysrhythmias, muscle weakness, and potential worsening of heart failure symptoms. Therefore, regular assessment of potassium levels allows for prompt intervention, such as potassium supplementation or adjusting the dosage of furosemide, to maintain electrolyte balance and optimize the client's cardiac function.
Regarding the other options:
- Blood glucose (Option A) is not directly related to furosemide therapy in heart failure.
- Serum sodium (Option B) may be affected by furosemide but is not as critical as monitoring potassium levels in this context.
- Blood urea nitrogen (BUN) (Option D) is an indicator of kidney function but is not the most crucial parameter to monitor when assessing the impact of furosemide on a client with heart failure.
Understanding the rationale behind prioritizing serum potassium monitoring in this scenario is essential for nurses caring for clients with heart failure receiving diuretic therapy. It emphasizes the significance of anticipating and managing potential electrolyte imbalances to promote positive patient outcomes and prevent complications related to medication therapy.